173 related articles for article (PubMed ID: 31956003)
1. High-Frequency Irreversible Electroporation for Treatment of Primary Liver Cancer: A Proof-of-Principle Study in Canine Hepatocellular Carcinoma.
Partridge BR; O'Brien TJ; Lorenzo MF; Coutermarsh-Ott SL; Barry SL; Stadler K; Muro N; Meyerhoeffer M; Allen IC; Davalos RV; Dervisis NG
J Vasc Interv Radiol; 2020 Mar; 31(3):482-491.e4. PubMed ID: 31956003
[TBL] [Abstract][Full Text] [Related]
2. Experimental High-Frequency Irreversible Electroporation Using a Single-Needle Delivery Approach for Nonthermal Pancreatic Ablation In Vivo.
O'Brien TJ; Passeri M; Lorenzo MF; Sulzer JK; Lyman WB; Swet JH; Vrochides D; Baker EH; Iannitti DA; Davalos RV; McKillop IH
J Vasc Interv Radiol; 2019 Jun; 30(6):854-862.e7. PubMed ID: 31126597
[TBL] [Abstract][Full Text] [Related]
3. Recovery of neurosurgical high-frequency electroporation injury in the canine brain can be accelerated by 7,8-dihydroxyflavone.
Sun G; Lin CH; Mei G; Gu J; Fan SF; Liu X; Liu R; Liu XW; Chen XS; Zhou C; Yi X; Jin P; Chang CP; Lin XJ
Biomed Pharmacother; 2023 Apr; 160():114372. PubMed ID: 36773524
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of primary canine hepatocellular carcinoma cell lines producing alpha-fetoprotein.
Kawarai S; Hashizaki K; Kitao S; Nagano S; Madarame H; Neo S; Ishikawa T; Furuichi M; Hisasue M; Tsuchiya R; Tsujimoto H; Yamada T
Vet Immunol Immunopathol; 2006 Sep; 113(1-2):30-6. PubMed ID: 16678911
[TBL] [Abstract][Full Text] [Related]
5. Immunological effect of irreversible electroporation on hepatocellular carcinoma.
Guo X; Du F; Liu Q; Guo Y; Wang Q; Huang W; Wang Z; Ding X; Wu Z
BMC Cancer; 2021 Apr; 21(1):443. PubMed ID: 33882892
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
7. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
[TBL] [Abstract][Full Text] [Related]
8. High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model.
Latouche EL; Arena CB; Ivey JW; Garcia PA; Pancotto TE; Pavlisko N; Verbridge SS; Davalos RV; Rossmeisl JH
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785285. PubMed ID: 30071778
[TBL] [Abstract][Full Text] [Related]
9. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in a young dog.
Teshima T; Matsumoto H; Shigihara K; Sawada H; Michishita M; Takahashi K; Koyama H
Can Vet J; 2013 Sep; 54(9):845-8. PubMed ID: 24155487
[TBL] [Abstract][Full Text] [Related]
11. Local ablation for hepatocellular carcinoma.
Boyvat F
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():55-9. PubMed ID: 24635794
[TBL] [Abstract][Full Text] [Related]
12. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
13. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma.
Matsuyama A; Takagi S; Hosoya K; Kagawa Y; Nakamura K; Deguchi T; Takiguchi M
N Z Vet J; 2017 Sep; 65(5):227-231. PubMed ID: 28441916
[TBL] [Abstract][Full Text] [Related]
15. Pathology in practice. Metastatic hepatocellular carcinoma in a dog.
Lamoureux JL; Carreira VS; Fitzgerald SD; Langohr IM; Smedley RC
J Am Vet Med Assoc; 2012 Dec; 241(12):1591-3. PubMed ID: 23216032
[No Abstract] [Full Text] [Related]
16. Intraoperative identification of canine hepatocellular carcinoma with indocyanine green fluorescent imaging.
Iida G; Asano K; Seki M; Ishigaki K; Teshima K; Yoshida O; Edamura K; Kagawa Y
J Small Anim Pract; 2013 Nov; 54(11):594-600. PubMed ID: 24580016
[TBL] [Abstract][Full Text] [Related]
17. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
[TBL] [Abstract][Full Text] [Related]
19. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation induces CD8
Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
